Description: Peregrine Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It develops novel investigational products that help utilize the immune system to fight cancer, also known as immunotherapy.
Home Page: www.avidbio.com
CDMO Technical Analysis
2642 Michelle Drive
Tustin,
CA
92780
United States
Phone:
714 508 6100
Officers
| Name | Title |
|---|---|
| Mr. Nicholas Stewart Green B.Sc., MBA | Pres, CEO & Director |
| Mr. Daniel R. Hart | Chief Financial Officer |
| Mr. Mark R. Ziebell J.D. | VP, Gen. Counsel & Corp. Sec. |
| Mr. Richard Richieri | Chief Operations Officer |
| Mr. Matthew Kwietniak | Chief Commercial Officer |
| Dr. Shelley P. M. Fussey | VP of Intellectual Property |
| Ms. Tracy L. Kinjerski | VP of Bus. Operations |
| Dr. Harold F. Dvorak M.D. | Medical & Scientific Advisor |
| Prof. Alan J. Schroit | Medical & Scientific Advisor |
| Prof. Rolf A. Brekken Ph.D. | Medical & Scientific Advisor |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 81.3008 |
|---|---|
| Trailing PE: | 8.8667 |
| Price-to-Book MRQ: | 4.9759 |
| Price-to-Sales TTM: | 6.3803 |
| IPO Date: | 2018-01-08 |
| Fiscal Year End: | April |
| Full Time Employees: | 321 |